Zuclopenthixol Short-Acting Intramuscular Injection Suppliers & Bulk Manufacturers

Available Forms: Short-acting Intramuscular Injection

Available Strengths: 50 mg/mL

Reference Brands: Clopixol-Acuphase®

Category: Antipsychotropic Drugs

Zuclopenthixol Short-acting Intramuscular Injection is available in Short-acting Intramuscular Injection and strengths such as 50 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Zuclopenthixol Short-acting Intramuscular Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Zuclopenthixol Short-acting Intramuscular Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Zuclopenthixol short-acting intramuscular injection, commonly used in acute psychosis and agitation, is not currently approved by the FDA in the United States but is available in several EU markets under Clopixol-Acuphase. In the EU, it follows EMA regulatory standards for parenteral antipsychotics, requiring GMP compliance, stability data, and clinical justification for emergency psychiatric use. U.S. registration would require a detailed regulatory strategy, including an IND or 505(b)(2) approach. To explore other dosage forms, strengths, and dossier-ready Zuclopenthixol IM injection products, visit Pharmatradz.com — your trusted global B2B platform for API and finished formulations.